Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 8.20
+0.07 (0.86%)
Oct 7, 2026, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 413.51 million as of October 7, 2026. Its market cap has decreased by -34.73% in one year.
Market Cap
413.51M
Enterprise Value
163.39M
Revenue
94.02M
Ranking
n/a
PE Ratio
12.28
Stock Price
8.20
ChartMarket Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 413.51M, an increase of 7,813.03%. That is a compound annual growth rate of 18.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 413.51M | -33.89% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 727.51M |
| Starpharma Holdings | 395.78M |
| Tetratherix | 351.78M |
| Racura Oncology | 347.04M |
| BLS Pharmaceuticals | 219.94M |
| Actinogen Medical | 203.94M |
| Orthocell | 193.36M |
| Paradigm Biopharmaceuticals | 146.80M |